AB Corporate Bond ETF (NASDAQ:EYEG) Short Interest Down 88.1% in August

Posted by Stanley Muller on Aug 26th, 2026

AB Corporate Bond ETF (NASDAQ:EYEG – Get Free Report) was the target of a significant decrease in short interest in the month of August. As of August 14th, there was short interest totaling 78 shares, a decrease of 88.1% from the July 30th total of 655 shares. Based on an average daily trading volume, of 861 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the company’s shares are short sold.

AB Corporate Bond ETF Trading Down 0.2%

Shares of EYEG stock traded down $0.06 during mid-day trading on Wednesday, reaching $34.66. The stock had a trading volume of 2,085 shares, compared to its average volume of 280. The firm has a market capitalization of $27.73 million, a PE ratio of -20.63 and a beta of 0.18. The stock’s 50-day moving average price is $34.85 and its two-hundred day moving average price is $35.21. The company has a current ratio of 3.07, a quick ratio of 3.07 and a debt-to-equity ratio of 0.01. AB Corporate Bond ETF has a 52-week low of $34.46 and a 52-week high of $36.63.

AB Corporate Bond ETF Increases Dividend

The firm also recently disclosed a monthly dividend, which was paid on Thursday, August 6th. Investors of record on Monday, August 3rd were paid a dividend of $0.1427 per share. The ex-dividend date of this dividend was Monday, August 3rd. This is an increase from AB Corporate Bond ETF’s previous monthly dividend of $0.14. This represents a c) annualized dividend and a yield of 4.9%. AB Corporate Bond ETF’s payout ratio is presently -102.38%.

Institutional Trading of AB Corporate Bond ETF

An institutional investor recently bought a new position in AB Corporate Bond ETF stock. Jane Street Group LLC purchased a new stake in shares of AB Corporate Bond ETF (NASDAQ:EYEG – Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 6,496 shares of the specialty pharmaceutical company’s stock, valued at approximately $232,000. Jane Street Group LLC owned about 0.87% of AB Corporate Bond ETF as of its most recent SEC filing. 64.16% of the stock is currently owned by hedge funds and other institutional investors.

AB Corporate Bond ETF Company Profile

(Get Free Report)

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.